(+)-JQ1 - JQ1

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1989

CAS [1268524-70-4]

MF C23H25ClN4O2S
MW 456.99

  • Purity: 99%
  • Optical purity: 99% ee
  • Soluble in DMSO



Potent and selective BET bromodomain inhibitor (IC50 values of 77 nM and 33 nM for inhibition of binding of a tetra-acetylated histone H4 peptide to BRD4 with the first and second bromodomain, respectively). (+)-JQ1 is capable of blocking the macrophage inflammatory responses via inhibition of BET proteins in mice, and activating HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Cotreatment with (+)-JQ1 and the FLT3 inhibitor AC220 (Axon 1696) synergistically induce apoptosis of cultured and primary CD34(+) human AML blast progenitor cells (BPC) expressing FLT3-ITD. Its negative control (-)-JQ1 (Axon 3873) is available as well.

KEYWORDS: (+)-JQ1 | BET inhibitor | JQ1 | JQ-1 | JQ 1 | CAS [1268524-70-4] | Histone | BET (BRD) | Inhibitor | Proteins | Bromodomain | inflammatory | HIV latency

Size Unit Price Stock
2 mg €60.00 In Stock
5 mg €90.00 In Stock
25 mg €290.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €140.00 In Stock
2 x 25 mg €460.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...